Delivery Order SPE2DB22D1106-SPE2DB25FEYM3
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 5-gram vials of Cyanokit, a medication used to treat cyanide poisoning. The contract has a ceiling value of $3,303.85 and a performance period extending through June 9, 2025. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,029.83 firm-fixed-price contract is for the supply of CYANOKIT 5 gram vials, a medication used to treat cyanide poisoning. The contract has an ultimate completion date of May 27, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CYANOKIT 5 gram vials, a medication used to treat cyanide poisoning. The contract has a firm fixed price of $3,544.33 and a period of performance through May 14, 2025. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This is a delivery order awarded to Amerisourcebergen Drug Corp under a $999,999,999 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4,565,481,613 CYANOKIT 5 gram vials, a critical medical product used for the treatment of cyanide poisoning. The delivery order has a ceiling value of $2,418.12 and a completion date of August 19, 2024. Amerisourcebergen, a major pharmaceutical distributor, is providing these...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CYANOKIT 5 gram vials. The contract has a ceiling value of $1,321.56 and an ultimate completion date of July 17, 2025. This award is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as...
- This is a $6,642.15 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CYANOKIT 5 gram vials, a specialized medical product, with a period of performance through May 19, 2025. The contract is not designated as a set-aside and is therefore open to full and open competition. AmerisourceBergen Drug Corp also holds a larger...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CYANOKIT 5 GRAM VL 1S, a medical product, with a ceiling value of $13,588.33 and a period of performance through July 29, 2025. The contract is designated as a firm fixed-price delivery order, with no set-aside used. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CYANOKIT 5 gram vials. The contract has a ceiling value of $1,321.56 and runs through April 2, 2025. It is a Firm Fixed Price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CYANOKIT 5 gram vials, with a ceiling value of $5,462.96 and a period of performance through July 1, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,360.83, is for the supply of 4,568,108,068 units of the CYANOKIT 5 gram vials. The award has an ultimate completion date of May 2, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the DLA Troop Support Medical,...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEYM3Delivery Order
The Defense Logistics Agency awarded a $1,321.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cyanokit 5-gram vials, with an ultimate completion date of July 21, 2025. This non-set-aside delivery order was competitively awarded and represents a single transaction under AmerisourceBergen's larger federal pharmaceutical supply contracts. Cyanokit (hydroxocobalamin) is a critical antidote used in emergency medical response for cyanide poisoning, making it essential inventory for military medical supply chains, first responder organizations, and emergency healthcare systems. This delivery order is issued under AmerisourceBergen's comprehensive Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, AmerisourceBergen serves as a prime vendor for federal medical procurement, supplying an extensive portfolio of medications, vaccines, and specialized medical supplies to support military healthcare programs and the Defense Health Agency. The company's history of competitively awarded delivery orders across multiple therapeutic domains demonstrates its capability to meet the Defense Logistics Agency's pharmaceutical supply requirements efficiently and reliably.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 7/18/25 |